DUBLIN, Feb. 13, 2019 /PRNewswire/ --
The "Europe Insulin Pump Market, Users, Reimbursement Policy, Countries (Germany, France, Netherlands, Switzerland, Sweden, and UK) Clinical Trials and Training Model Analysis" report has been added to ResearchAndMarkets.com's offering.
Europe insulin pump market is projected to be more than US$ 2.4 Billion by the end of the year 2024.
The numbers of factors contributing to the growth of insulin pump in Europe are growing the aging population, increasing the prevalence of diabetes, raising awareness regarding benefits of an insulin pump, increasing per capita disposable income and progressive diabetes infrastructure. Although the potential of insulin pump market in Europe is very high due to its large diabetes population.
Gradually advancement of insulin pumps and its skyrocket adoption among diabetes patient over conventional techniques are opening solid opportunities for the insulin pump market in Europe. On contrary, the high cost of an insulin pump, inadequate reimbursement policies and availability of others substitutes are hindering the insulin pump market in Europe.
Europe is one of the best regions in the world, where healthcare provider is well aligned and diabetes institutional network are properly scattered to capture the whole demography. Thus service is available for everyone in terms of diabetes training for healthcare certified professional (HCP), assistant staff and new patients. Moreover, there is a large number of insulin pump manufacturer in Europe launching new products from time to time with great advancement and features.
Germany is one of the biggest markets for Insulin Pump in Europe
In Europe, Germany is one of the biggest markets for insulin pump due to its large number of a diabetes patient, type 1 diabetes patient, and improved reimbursement policies. The report covers the following 6 European countries Diabetes insulin pump market, insulin pump users its growth forecast, Number of Type 1 and Type 2 diabetes population in each country.
Europe Insulin Pump Reimbursement Policies
This report covers in-depth analysis of Insulin pump reimbursement policy of 6 major countries in Europe (Germany, France, Netherlands, Switzerland, Sweden and United Kingdom). In this report, we also covered diabetes national framework and priority of the government. In addition, we mentioned what criteria are required to get insulin pump reimbursed.
The scope of the Report:
- Insulin Pump Market & Forecast: This report comprises of the insulin pump market and volume of the user of 6 countries. Market data from 2010 to 2017 and Forecast period from 2018 to 2024.
- Reimbursement Policy: Report covers the details of separate reimbursement policy for 6 countries including Insulin Pumps, Diabetes Supplies (Blood Glucose Devices, Test Strips, Lancets, Disposable Needles, Syringe, Ketone Urine Testing Strips, and Pen Delivery etc)
- Training Models: This topic shows through flow chart method, how a company provides training. This segment company Training program for its staff includes physicians, Certified Diabetes Educators (including nurse educators, dietitians, and exercise physiologists) and support staff with expertise in insulin pump therapy and Training program for patients have been described through flow chart method.
- Differentiation Points of Insulin Pump Products: This report discusses pros and cons of the insulin pumps: Animas Vibe, Medtronic 530G with Enlite, Insulet OmniPod, Tandem t: slim, Roche Accu-Chek Combo.
- Clinical Trials of Insulin Pumps: This report covers the details of clinical trials results for companies on Insulin Pumps. Following are the details of the companies associated with insulin pumps- Medtronic, Insulet Corporation, Tandem Diabetes Care, Roche and Animas Corporation.
- Growth Drivers for Insulin Pumps: This report tells about the factors which are helping the Insulin Pump industry to grow.
- Challenges for Insulin Pumps: This report covers the problems being faced by the insulin Pump industry.
Key Topics Covered:
1. Executive Summary
2. Europe Insulin Pump Users (2010 - 2024)
3. Europe Insulin Pump Market (2010 - 2024)
4. Market Share - Europe Insulin Pump (2010 - 2024)
4.1 Countries
5. Training Model for Patients & HCP - of Medtronic, Animas, Insulet Corp & Tandem Diabetes Care
5.1 Medtronic
5.1.1 Training Guidelines for Insulin Pump Therapy to New Patients
5.1.2 Training Model for HCP (HealthCare Professional)
5.2 Insulet Corporation
5.2.1 Training Structure for New Patients - Insulet Corporation
5.3 Animas Corporation
5.3.1 Training Modules for New Patients
5.3.2 Training Modules for HCP (Health Care Professional)
5.4 Tandem Diabetes Care
6. Differentiation Points of Insulin Pump Products
6.1 Animas Vibe
6.2 Medtronic 530G with Enlite
6.3 Insulet OmniPod
6.4 Tandem t:slim
6.5 Roche Accu-Chek Combo
7. United Kingdom - Diabetes Population (2010 - 2024)
7.1 United Kingdom - Total Diabetes Population
7.1.1 Type 1 Diabetes Population
7.1.2 Type 2 Diabetes Population
8. United Kingdom Insulin Pump Analysis (2010 - 2024)
8.1 Insulin Pump Users & Forecast
8.2 Insulin Pump Market & Forecast
8.3 Reimbursement Policies on Insulin Pump
9. Germany - Diabetes Population (2010 - 2024)
9.1 Germany - Total Diabetes Population
9.1.1 Type 1 Diabetes Population
9.1.2 Type 2 Diabetes Population
10. Germany Insulin Pump Analysis (2010 - 2024)
10.1 Insulin Pump Users
10.2 Germany Insulin Pump Market & Forecast
10.3 Reimbursement Policies on Insulin Pump
11. Netherlands - Diabetes Population (2010 - 2024)
11.1 Netherlands - Total Diabetes Population
11.1.1 Type 1 Diabetes Population
11.1.2 Type 2 Diabetes Population
12. Netherlands Insulin Pump Analysis (2010 - 2024)
12.1 Insulin Pump Users & Forecast
12.2 Insulin Pump Market & Forecast
12.3 Reimbursement Policies on Insulin Pump
13. Sweden - Diabetes Population (2010 - 2024)
13.1 Sweden - Total Diabetes Population
13.1.1 Type 1 Diabetes Population
13.1.2 Type 2 Diabetes Population
14. Sweden Insulin Pump Analysis (2010 - 2024)
14.1 Insulin Pump Users & Forecast
14.2 Insulin Pump Market & Forecast
14.3 Reimbursement Policies on Insulin Pump
15. France - Diabetes Population (2010 - 2024)
15.1 France - Total Diabetes Population
15.1.1 Type 1 Diabetes Population
15.1.2 Type 2 Diabetes Population
16. France Insulin Pump Analysis (2010 - 2024)
16.1 Insulin Pump Users & Forecast
16.2 Insulin Pump Market & Forecast
16.3 Reimbursement Policies on Insulin pump
17. Switzerland - Diabetes Population (2010 - 2024)
17.1 Switzerland - Total Diabetes Population
17.1.1 Type 1 Diabetes Population
17.1.2 Type 2 Diabetes Population
18. Switzerland Insulin Pump Analysis (2010 - 2024)
18.1 Insulin Pump Users & Forecast
18.2 Insulin Pump Market & Forecast
18.3 Reimbursement Policies on Insulin Pump
19. Companies - Insulin Pump Clinical Trials
19.1 Medtronic
19.2 Insulet Corporation
19.3 Tandem Diabetes Care
19.4 Roche
19.5 Animas Corporation
20. Growth Drivers
20.1 Benefits of Insulin Pump over Multiple Daily Injections
20.2 Lifestyle-Compatible Treatment Options and Technological Advancement in Insulin Pump Devices
21. Challenges
21.1 Safety Issues in Insulin Pump Devices
21.2 Difficulties Associated with the Pump
For more information about this report visit https://www.researchandmarkets.com/research/h3cgsm/europe_insulin?w=5
Research and Markets also offers Custom Research services providing focused, comprehensive and tailored research.
Media Contact:
Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com
For E.S.T Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
View original content:http://www.prnewswire.com/news-releases/europe-insulin-pump-market-2010-2024-featuring-animas-vibe-medtronic-530g-with-enlite-insulet-omnipod-tandem-t-slim--roche-accu-chek-combo-300794312.html
SOURCE Research and Markets
